HOOKIPA Pharma Inc.
HOOK
$0.7896
-$0.0354-4.29%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 43.95M | 50.00M | 52.16M | 53.55M | 20.13M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 43.95M | 50.00M | 52.16M | 53.55M | 20.13M |
| Cost of Revenue | 47.54M | 55.70M | 64.76M | 64.92M | 65.68M |
| Gross Profit | -3.59M | -5.71M | -12.60M | -11.36M | -45.55M |
| SG&A Expenses | 21.60M | 20.45M | 18.63M | 19.13M | 19.98M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 88.73M | 95.75M | 102.99M | 103.45M | 105.06M |
| Operating Income | -44.79M | -45.75M | -50.83M | -49.90M | -84.93M |
| Income Before Tax | -43.61M | -43.21M | -48.43M | -47.35M | -81.21M |
| Income Tax Expenses | -106.00K | 164.00K | 164.00K | 164.00K | 369.00K |
| Earnings from Continuing Operations | -43.50 | -43.37 | -48.60 | -47.52 | -81.58 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -43.50M | -43.37M | -48.60M | -47.52M | -81.58M |
| EBIT | -44.79M | -45.75M | -50.83M | -49.90M | -84.93M |
| EBITDA | -42.03M | -42.42M | -47.71M | -46.63M | -81.38M |
| EPS Basic | -3.47 | -3.68 | -4.30 | -4.96 | -8.83 |
| Normalized Basic EPS | -1.84 | -1.47 | -1.91 | -2.32 | -4.79 |
| EPS Diluted | -3.52 | -3.73 | -4.35 | -5.01 | -8.83 |
| Normalized Diluted EPS | -1.85 | -1.47 | -1.91 | -2.32 | -4.79 |
| Average Basic Shares Outstanding | 50.16M | 48.90M | 47.40M | 43.13M | 37.81M |
| Average Diluted Shares Outstanding | 50.21M | 48.96M | 47.46M | 43.19M | 37.81M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
